Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology

抗体

山羊抗人类CDKN2A(C-末端)

AHP1060

0.1毫克

496美元

多克隆

domestic goat

未共轭

免疫印迹, 酶联免疫吸附测定

抗体

(C-末端)

AHP1060

山羊抗人类CDKN2A(C-末端)

CDKN2A

人类

山羊

纯化

多克隆IgG

E, 免疫印迹

西方墨点法, 酶联免疫吸附测定

0.1毫克

0.1

毫克

GO:0001953, GO:0005515, GO:0000080, GO:0000082, GO:0000075, GO:0019901, GO:0030308, GO:0007050, GO:0007265, GO:0008285, GO:0005829, GO:0004861, GO:0005634, GO:0006917, GO:0090398, GO:0070215, GO:0055105, GO:0051444, GO:0071158, GO:0070534, GO:0006364, GO:0006917, GO:0006469, GO:0006919, GO:0007050, GO:0008637, GO:0010389, GO:0050821, GO:0016563, GO:0033088, GO:0031648, GO:0030889, GO:0043517, GO:0043234, GO:0045944, GO:0048103, GO:0046825, GO:0005730, GO:0006309, GO:0006350, GO:0003677, GO:0005654, GO:0002039, GO:0005515, GO:0000209, GO:2000111, GO:0051059, GO:0090399, GO:0045736, GO:0032088, GO:0034393

alpha-2 macroglobulin receptor-associated protein activity,GO:0045308,protein amino acid binding,protein degradation tagging activity,protein folding chaperone,protein tagging activity,down regulation of cell-matrix adhesion,down-regulation of cell-matrix adhesion,downregulation of cell-matrix adhesion,inhibition of cell-matrix adhesion,CDK inhibitor,cyclin dependent kinase inhibitor,cyclin dependent protein kinase inhibitor activity,cyclin-dependent kinase inhibitor,cell nucleus,activation of apoptosis,apoptosis activator activity,apoptosis signaling,commitment to apoptosis,induction of apoptosis by p53,arrest of cell cycle progression,cessation of cell cycle,termination of cell cycle,Ras mediated signal transduction,down regulation of cell proliferation,downregulation of cell proliferation,down-regulation of cell proliferation,inhibition of cell proliferation,down regulation of cell growth,downregulation of cell growth,down-regulation of cell growth,inhibition of cell growth,inhibition of NF-kappaB transcription factor,NF-kappaB inhibitor,activation of smooth muscle cell apoptosis,positive regulation of SMC apoptosis,stimulation of smooth muscle cell apoptosis,up regulation of smooth muscle cell apoptosis,upregulation of smooth muscle cell apoptosis,up-regulation of smooth muscle cell apoptosis,CDK inhibitor,cyclin-dependent kinase inhibitor,down regulation of cyclin-dependent protein kinase activity,down-regulation of cyclin-dependent protein kinase activity,downregulation of cyclin-dependent protein kinase activity,inhibition of cyclin-dependent protein kinase activity,negative regulation of CDK activity,polyubiquitin,protein polyubiquitinylation,protein polyubiquitylation,alpha-2 macroglobulin receptor-associated protein activity,GO:0045308,protein amino acid binding,protein degradation tagging activity,protein folding chaperone,protein tagging activity,microtubule/chromatin interaction,plasmid binding,DNA catabolic process during apoptosis,DNA catabolism during apoptosis,DNA fragmentation,endonucleolytic DNA catabolic process involved in apoptosis,GO:0008178,cellular transcription,GO:0061018,35S primary transcript processing,GO:0006365,down regulation of protein kinase activity,downregulation of protein kinase activity,down-regulation of protein kinase activity,inhibition of protein kinase activity,activation of apoptosis,apoptosis activator activity,apoptosis signaling,commitment to apoptosis,induction of apoptosis by p53,caspase activation,arrest of cell cycle progression,cessation of cell cycle,termination of cell cycle,regulation of mitotic entry,GO:0003710,transcription activating factor,transcriptional activator activity,lysosomal protein stabilization,positive regulation of protein stability,protein sequestering,protein stabilization activity,down regulation of B cell proliferation,downregulation of B cell proliferation,down-regulation of B cell proliferation,inhibition of B cell proliferation,negative regulation of B lymphocyte proliferation,negative regulation of B-cell proliferation,negative regulation of B-lymphocyte proliferation,negative regulation of protein stability,negative regulation of thymic T cell proliferation,negative regulation of thymocyte cell proliferation,negative regulation of thymocyte proliferation,protein-protein complex,activation of DNA damage response, signal transduction by p53 class mediator,positive regulation of p53 induced by DNA damage response,stimulation of DNA damage response, signal transduction by p53 class mediator,up regulation of DNA damage response, signal transduction by p53 class mediator,upregulation of DNA damage response, signal transduction by p53 class mediator,up-regulation of DNA damage response, signal transduction by p53 class mediator,activation of transcription from RNA polymerase II promoter,positive regulation of transcription from Pol II promoter,stimulation of transcription from RNA polymerase II promoter,up regulation of transcription from RNA polymerase II promoter,upregulation of transcription from RNA polymerase II promoter,up-regulation of transcription from RNA polymerase II promoter,regulation of protein export from cell nucleus,regulation of protein export out of nucleus,regulation of protein transport from nucleus to cytoplasm,regulation of protein-nucleus export,somatic stem cell renewal,anaphase promoting complex inhibition,anaphase promoting complex inhibitor,anaphase-promoting complex inhibition,anaphase-promoting complex inhibitor,APC inhibition,APC inhibitor,down regulation of ubiquitin ligase activity,downregulation of ubiquitin ligase activity,down-regulation of ubiquitin ligase activity,inhibition of ubiquitin ligase activity,negative regulation of ubiquitin ligase activity,SCF complex inhibitor,ubiquitin ligase inhibitor

Q8N726, P42771

CDKN2A, CDKN2A

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1029, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1029

p16INK4a

纯化

41116161

IgG浓度0.5毫克/毫升

纯化IgG-液体

355

496

496美元

540.64

5213

5312

3700

加拿大